Catherine m. phelan
Deparment of Cancer Epidemiology
Moffitt Cancer Center
United States of America
Dr. Catherine M. Phelan is affiliated to Deparment of Cancer Epidemiology, Moffitt Cancer Center. Dr. Catherine M. Phelan is currently providing services as Researcher. Dr. Catherine M. Phelan has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Catherine M. Phelan contributions have acclaimed recognition from honourable subject experts around the world. Dr. Catherine M. Phelan is actively associated with different societies and academies. Dr. Catherine M. Phelan academic career is decorated with several reputed awards and funding. Dr. Catherine M. Phelan research interests include Dr. Phelan’s main research interests are to investigate the etiology of cancer susceptibility, in the context of high, intermediate and low penetrance alleles. This research encompasses both the nuclear and mitochondrial genome in ovarian, breast and prostate cancer..
Dr. Phelan’s main research interests are to investigate the etiology of cancer susceptibility, in the context of high, intermediate and low penetrance alleles. This research encompasses both the nuclear and mitochondrial genome in ovarian, breast and prostate cancer.
Reid BM, Permuth JB, Chen YA, Teer JK, Monteiro AN, Chen Z, Tyrer J, Berchuck A, Chenevix-Trench G, Doherty JA, Goode EL. Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci. Cancer Epidemiology and Prevention Biomarkers. 2017 Jan 1;26(1):116-25.
Luu HN, Lin HY, Sørensen KD, Ogunwobi OO, Kumar N, Chornokur G, Phelan C, Jones D, Kidd L, Batra J, Yamoah K. miRNAs associated with prostate cancer risk and progression. BMC urology. 2017 Mar 20;17(1):18.
Gu F, Zhang H, Hyland PL, Berndt S, Gapstur SM, Wheeler W, Amos CI, Bezieau S, Bickeböller H, Brenner H, Brennan P. Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia. International Journal of Cancer. 2017 Aug 25.